
[Federal Register: February 24, 2009 (Volume 74, Number 35)]
[Notices]               
[Page 8266]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24fe09-83]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]

 
Arthritis Advisory Committee; Notice of Postponement of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is postponing the 
meeting of the Arthritis Advisory Committee scheduled for March 5, 
2009. This meeting was announced in the Federal Register of January 29, 
2009 (74 FR 5165). The postponement is due to the need to complete the 
review of additional data submitted by the applicant. Future meeting 
dates will be announced in the Federal Register.

FOR FURTHER INFORMATION CONTACT: Nicole Vesely, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-6793, FAX: 301-827-6776, e-mail: 
nicole.vesely@fda.hhs.gov, or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512532. Please call the Information Line for up-to-date information 
on this meeting.

    Dated: February 17, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9-3830 Filed 2-23-09; 8:45 am]

BILLING CODE 4160-01-S
